SMOFlipid to Lessen the Severity of Neonatal Cholestasis
NCT02721277
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Cholestasis
Jaundice, Obstructive
Interventions
DRUG:
SMOFlipid
Sponsor
University of Florida